Nebulization of the acidified sodium nitrite formulation attenuates acute hypoxic pulmonary vasoconstriction

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Egemnazarov, Bakytbek ^a   Schermuly, Ralph T ^a,b   Dahal, Bhola K ^a   Elliott, Garry T ^c   Hoglen, Niel C ^c   Surber, Mark W ^c   Weissmann, Norbert ^a   Grimminger, Friedrich ^a   Seeger, Werner ^a   Ghofrani, Hossein A ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^c Aires Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; NITRIC OXIDE; SODIUM NITRITE; NITRATE; VASODILATOR AGENT;

ACUTE HYPOXIC PULMONARY VASOCONSTRICTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD GAS; CONTROLLED STUDY; DRUG FORMULATION; DRUG POTENCY; DRUG TOLERABILITY; ERYTHROCYTE; EX VIVO STUDY; HEART OUTPUT; HYPOXIC LUNG VASOCONSTRICTION; IN VIVO STUDY; ISOLATED LUNG; LUNG ARTERY PRESSURE; MALE; NEBULIZATION; NONHUMAN; RABBIT; ACUTE DISEASE; ANIMAL; ANOXIA; BLOOD; BLOOD PRESSURE; CHEMISTRY; COMPARATIVE STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; EXHALATION; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; NEBULIZER; PATHOPHYSIOLOGY; PERFUSION; PH; PULMONARY ARTERY; TIME; VASOCONSTRICTION;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ANIMALS; ANOXIA; BLOOD PRESSURE; CARDIAC OUTPUT; CHEMISTRY, PHARMACEUTICAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXHALATION; HYDROGEN-ION CONCENTRATION; MALE; NEBULIZERS AND VAPORIZERS; NITRATES; NITRIC OXIDE; PERFUSION; PULMONARY ARTERY; RABBITS; SODIUM NITRITE; TIME FACTORS; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 77956667516     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-81     Document Type: Article

References (31)

1. Moudgil R, Michelakis ED, Archer SL. Hypoxic pulmonary vasoconstriction. J Appl Physiol 2005, 98(1):390-403. 10.1152/japplphysiol.00733.2004, 15591309.
2. Wagner PD. Reduced maximal cardiac output at altitude--mechanisms and significance. Respir Physiol 2000, 120(1):1-11. 10.1016/S0034-5687(99)00101-2, 10786640.
3. Wright JL, Levy RD, Churg A. Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment. Thorax 2005, 60(7):605-609. 10.1136/thx.2005.042994, 1747459, 15994270.
4. Adnot S, Raffestin B, Eddahibi S. NO in the lung. Respir Physiol 1995, 101(2):109-120. 10.1016/0034-5687(95)00016-7, 8570913.
5. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991, 83(6):2038-2047.
6. Weissmann N, Voswinckel R, Tadic A, Hardebusch T, Ghofrani HA, Schermuly RT, Seeger W, Grimminger F. Nitric oxide (NO)-dependent but not NO-independent guanylate cyclase activation attenuates hypoxic vasoconstriction in rabbit lungs. Am J Respir Cell Mol Biol 2000, 23(2):222-227.
7. Dumitrascu R, Weissmann N, Ghofrani HA, Dony E, Beuerlein K, Schmidt H, Stasch JP, Gnoth MJ, Seeger W, Grimminger F, Schermuly RT. Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling. Circulation 2006, 113(2):286-295. 10.1161/CIRCULATIONAHA.105.581405, 16391154.
8. Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 2008, 7(2):156-167. 10.1038/nrd2466, 18167491.
9. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, Zalos G, Xu X, Huang KT, Shields H, Kim-Shapiro DB, Schechter AN, Cannon RO, Gladwin MT. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 2003, 9(12):1498-1505. 10.1038/nm954, 14595407.
10. Millar TM, Stevens CR, Benjamin N, Eisenthal R, Harrison R, Blake DR. Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett 1998, 427(2):225-228. 10.1016/S0014-5793(98)00430-X, 9607316.
11. Zweier JL, Samouilov A, Kuppusamy P. Non-enzymatic nitric oxide synthesis in biological systems. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1999, 1411(2-3):250.
12. Mirvish SS, Wallcave L, Eagen M, Shubik P. Ascorbate-nitrite reaction: possible means of blocking the formation of carcinogenic N-nitroso compounds. Science 1972, 177(43):65-68. 10.1126/science.177.4043.65, 5041776.
13. May JM. How does ascorbic acid prevent endothelial dysfunction?. Free Radical Biology and Medicine 2000, 28(9):1421. 10.1016/S0891-5849(00)00269-0, 10924860.
14. Modin A, Bjorne H, Herulf M, Alving K, Weitzberg E, Lundberg JO. Nitrite-derived nitric oxide: a possible mediator of 'acidic-metabolic' vasodilation. Acta Physiol Scand 2001, 171(1):9-16. 10.1046/j.1365-201x.2001.171001009.x, 11350258.
15. Deem S, Min JH, Moulding JD, Eveland R, Swenson ER. Red blood cells prevent inhibition of hypoxic pulmonary vasoconstriction by nitrite in isolated, perfused rat lungs. Am J Physiol Heart Circ Physiol 2007, 292(2):H963-970. 10.1152/ajpheart.00812.2006, 17012349.
16. Hunter CJ, Dejam A, Blood AB, Shields H, Kim-Shapiro DB, Machado RF, Tarekegn S, Mulla N, Hopper AO, Schechter AN, Power GG, Gladwin MT. Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator. Nat Med 2004, 10(10):1122-1127. 10.1038/nm1109, 15361865.
17. Dejam A, Hunter CJ, Tremonti C, Pluta RM, Hon YY, Grimes G, Partovi K, Pelletier MM, Oldfield EH, Cannon RO, Schechter AN, Gladwin MT. Nitrite Infusion in Humans and Nonhuman Primates: Endocrine Effects, Pharmacokinetics, and Tolerance Formation. Circulation 2007, 116(16):1821-1831. 10.1161/CIRCULATIONAHA.107.712133, 17893272.
18. Maher AR, Milsom AB, Gunaruwan P, Abozguia K, Ahmed I, Weaver RA, Thomas P, Ashrafian H, Born GV, James PE, Frenneaux MP. Hypoxic modulation of exogenous nitrite-induced vasodilation in humans. Circulation 2008, 117(5):670-677. 10.1161/CIRCULATIONAHA.107.719591, 18212289.
19. Gribbe T, Gustafsson LE, Wiklund NP. Transdermally administered nitric oxide by application of acidified nitrite increases blood flow in rat epigastric island skin flaps. European Journal of Pharmacology 2008, 578(1):51. 10.1016/j.ejphar.2007.09.032, 17976572.
20. Brilli RJ, Krafte-Jacobs B, Smith DJ, Passerini D, Moore L, Ballard ET. Aerosolization of novel nitric oxide donors selectively reduce pulmonary hypertension. Crit Care Med 1998, 26(8):1390-1396. 10.1097/00003246-199808000-00026, 9710099.
21. Seeger W, Menger M, Walmrath D, Becker G, Grimminger F, Neuhof H. Arachidonic acid lipoxygenase pathways and increased vascular permeability in isolated rabbit lungs. Am Rev Respir Dis 1987, 136(4):964-972.
22. Ghofrani HA, Kohstall MG, Weissmann N, Schmehl T, Schermuly RT, Seeger W, Grimminger F. Alveolar epithelial barrier functions in ventilated perfused rabbit lungs. Am J Physiol Lung Cell Mol Physiol 2001, 280(5):L896-904.
23. Spriestersbach R, Grimminger F, Weissmann N, Walmrath D, Seeger W. On-line measurement of nitric oxide generation in buffer-perfused rabbit lungs. J Appl Physiol 1995, 78(4):1502-1508.
24. Schermuly RT, Ghofrani HA, Enke B, Weissmann N, Grimminger F, Seeger W, Schudt C, Walmrath D. Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension. Am J Respir Crit Care Med 1999, 160(5):1500-1506.
25. Doyle MP, Pickering RA, DeWeert TM, Hoekstra JW, Pater D. Kinetics and mechanism of the oxidation of human deoxyhemoglobin by nitrites. J Biol Chem 1981, 256(23):12393-12398.
26. van Faassen EE, Bahrami S, Feelisch M, Hogg N, Kelm M, Kim-Shapiro DB, Kozlov AV, Li H, Lundberg JO, Mason R, Nohl H, Rassaf T, Samouilov A, Slama-Schwok A, Shiva S, Vanin AF, Weitzberg E, Zweier J, Gladwin MT. Nitrite as regulator of hypoxic signaling in mammalian physiology. Med Res Rev 2009, 29(5):683-741. 10.1002/med.20151, 2725214, 19219851.
27. Zweier JL, Wang P, Samouilov A, Kuppusamy P. Enzyme-independent formation of nitric oxide in biological tissues. Nat Med 1995, 1(8):804-809. 10.1038/nm0895-804, 7585184.
28. Zweier JL, Samouilov A, Kuppusamy P. Non-enzymatic nitric oxide synthesis in biological systems. Biochim Biophys Acta 1999, 1411(2-3):250-262. 10.1016/S0005-2728(99)00018-3, 10320661.
29. Dalsgaard T, Simonsen U, Fago A. Nitrite-dependent vasodilation is facilitated by hypoxia and is independent of known NO-generating nitrite reductase activities. Am J Physiol Heart Circ Physiol 2007, 292(6):H3072-3078. 10.1152/ajpheart.01298.2006, 17307993.
30. Crawford JH, Isbell TS, Huang Z, Shiva S, Chacko BK, Schechter AN, Darley-Usmar VM, Kerby JD, Lang JD, Kraus D, Ho C, Gladwin MT, Patel RP. Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood 2006, 107(2):566-574. 10.1182/blood-2005-07-2668, 1895612, 16195332.
31. Casey DB, Badejo AM, Dhaliwal JS, Murthy SN, Hyman AL, Nossaman BD, Kadowitz PJ. Pulmonary vasodilator responses to sodium nitrite are mediated by an allopurinol-sensitive mechanism in the rat. Am J Physiol Heart Circ Physiol 2009, 296(2):H524-533. 10.1152/ajpheart.00543.2008, 2643888, 19074675.